US 12383536
CRF receptor antagonists and methods of use
granted A61KA61K31/427A61P
Quick answer
US patent 12383536 (CRF receptor antagonists and methods of use) held by Neurocrine Biosciences, Inc. expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/427, A61P, A61P5/38